We are live on ! Find out more
NRXPW

NRX Pharmaceuticals Warrant
NRXPW

Delisted

NRXPW was delisted on the 22nd of May, 2026.

Back to rankings

16 hedge funds and large institutions have $593K invested in NRX Pharmaceuticals Warrant in 2018 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

7% more funds holding

Funds holding: 15 → 16 (+1)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

37% less capital invested

Capital invested by funds: $934K → $593K (-$341K)

Holders
16
Holders Change
+1
Holders Change %
+6.67%
% of All Funds
0.36%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$9.76K
2
BI
Bulldog Investors
New Jersey
+$7.29K
3
UBS Group
UBS Group
Switzerland
+$1.77K

Top Sellers

Rank Fund Capital Flow
1
CI
Cowen Inc
New York
-$9K
Name Holding Trade Value Shares
Change 		Change in
Stake
BI
1
Bulldog Investors
New Jersey
$85K +$7.29K +21,050 +17%
PAMP
2
Polar Asset Management Partners
Ontario, Canada
$77K – – –
VAS
3
VR Advisory Services
Cayman Islands
$62K – – –
WCMNY
4
Westchester Capital Management (New York)
New York
$47K – – –
OAM
5
Oxford Asset Management
United Kingdom
$40K – – –
KPF
6
K2 Principal Fund
Ontario, Canada
$39K – – –
AA
7
AQR Arbitrage
Connecticut
$38K – – –
PC
8
Periscope Capital
Ontario, Canada
$38K – – –
RCM
9
Rivernorth Capital Management
Florida
$36K – – –
6CM
10
683 Capital Management
New York
$32K – – –
YCM
11
Yakira Capital Management
Connecticut
$32K – – –
LIM
12
Longfellow Investment Management
Massachusetts
$22K – – –
GCL
13
Glazer Capital LLC
New York
$19K – -1 -0%
BFM
14
Boothbay Fund Management
New York
$13K – – –
Susquehanna International Group
15
Susquehanna International Group
Pennsylvania
$11K +$9.76K +28,168 New
UBS Group
16
UBS Group
Switzerland
$2K +$1.77K +5,100 New
CI
17
Cowen Inc
New York
– -$9K -20,043 Closed

NRXPW Hedge Fund Activity: Q4 2018 in Review

16 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in NRX Pharmaceuticals Warrant (NRXPW) for Q4 2018, worth a combined $593K — down 37% from $934K a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new NRXPW positions and 1 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $9.76K. The largest seller was Cowen Inc, exiting entirely with an estimated $9K sold.

  • 16 institutional investors held NRX Pharmaceuticals Warrant (NRXPW) as of Q4 2018, up from 15 in Q3 2018.
  • Funds reported $593K of NRX Pharmaceuticals Warrant stock for Q4 2018, down 37% quarter-over-quarter.
  • 2 funds opened new NRX Pharmaceuticals Warrant positions in Q4 2018 and 1 closed out, a net change of +1 holder.
  • The largest NRX Pharmaceuticals Warrant buyer in Q4 2018 was Susquehanna International Group, an estimated $9.76K added.
  • The largest NRX Pharmaceuticals Warrant seller in Q4 2018 was Cowen Inc, an estimated $9K sold.

Based on aggregated 13F filings for Q4 2018.